Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:42 PM
Ignite Modification Date: 2025-12-25 @ 12:37 PM
NCT ID: NCT00278395
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00278395
Study Brief: Vorinostat in Treating Patients With Kidney Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vorinostat The dose of vorinostat was 300 mg two times a day on the first 3 days of every week on a 4-week cycle. None None 1 14 7 14 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Shortness of Breath SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Congestive Heart Failure SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea None Gastrointestinal disorders None View
Fatigue None Blood and lymphatic system disorders None View
Weight loss None Gastrointestinal disorders None View
Diarrhea None Gastrointestinal disorders None View
Vomiting None Gastrointestinal disorders None View